Introduction of stage classification and promotion of personalized medicine in IgG4-related diseases

Introduction of stage classification and promotion of personalized medicine in IgG4-related diseases - Introduction of stage classification in IgG4-related diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034620

Enrollment

Registered

2018-10-24

Start date

2018-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with IgG4-related disease, who are over 20 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Analyzing the each serum cytokine concentration and the expression of cytokine mRNA in the involved organs	—

Countries

Japan

Contacts

Public ContactMotohisa YAMAMOTO

Sapporo Medical University School of Medicine Department of Rheumatology and Clinical Immunology

mocha@sapmed.ac.jp011-611-2111

Outcome results